2016 Report details for project: General Practice System of Choice (GPSoC) Replacement

Project name: General Practice System of Choice (GPSoC) Replacement - there are 4 reports for this project: 2014, 2015, 2016, 2017
Google search: Google search on project name (opens in new window) opens in new window
Organisation: DOH (D12) - see all reports for this organisation
Report year: 2016 (data is from Sept 2015)
Category: ICT - see all reports for this category
Description: GPSoC Replacement Project: Continued funding for the provision and development of the GP clinical IT systems used in all practices in England by appointing a range of suppliers to a procurement framework, offering GP practices a choice of systems from a diverse market
DCA (RAG): Amber/Green
DCA text: The overall assessment of delivery confidence is AMBER/GREEN based on the Senior Responsible Owner's current view (as at Q2 2015/16) and due to the following main risks and issues that are being managed: • An Addendum to the Business Case is continuing through the approvals process. • Resource capacity within Health & Social Care Information Centre continues to be under planned against requirements, specifically business analysts, account manager and commercial roles. • Principal Clinical System supplier delivery progresses at pace. However, some suppliers are rebaselining delivery plans, as a result of their move to a new technology platform. • With regard to the Interface Mechanism, engagement with existing suppliers and potential new suppliers is underway in order to bring more suppliers through the delivery pipeline. To date there are 56 suppliers at various stages of engagement within the pairing process. • For the GP Connect (Common Interface) project, the possibility of using middleware to implement Application Programming Interfaces and facilitate the pairing process is being investigated via a Proof of Concept.
Start date: 2012-01-26
End date: 2015-03-31
Schedule text: The original Project End Date for the General Practice System of Choice Replacement Project was 31/03/15. An extension was requested and approved to extend the End Date to 31/10/15. A seven month extension was required because: • Supplier delays have impacted the delivery of Entry and Standard Requirements within required operational service dates. • Suppliers are late in the delivery of General Practice System of Choice Services specifically against Principal Clinical System and National Services (Summary Care Record and GP2GP) Requirements. • Current General Practice System of Choice Interface Mechanism pairing process has been limited due to delayed delivery of Principal Interface Management requirements, assurance of Subsidiary Supplier systems and the evolvement of supporting processes and test environments. This in turn may impact the ability to deliver Subsidiary Supplier pairings. • Programme and Commercial resource shortage is impacting the ability to deliver commissioned projects. The Programme is aiming for the project to move into Business As Usual following the approval our the Project Closure Report by the end of the financial year 2015/16.
Baseline: £87.32m
Forecast: £82.13m
Variance: -5.93%
Variance text: Budget figures from the Appointment Business Case (17 March 2014) include contingency in FY15/16, but contingency is not included in the forecast figures. Clinical Commissioning Group costs have been included in the forecast at the rate given in the business case. Two different sets of variances have arisen since the Appointment Business Case was approved due to contract negotiations were still ongoing during the approval of the Appointment Business Case, and as a result of delays to the delivery of the new services. Further reductions will follow as a result of restrictions to subsidiary module deployments between now and Dec 2016 which are needed to ensure that the costs remain within the business case allocation for the follow on term.
Whole Life Cost: £309.43m
WLCost text: The whole life cost for the General Practice System of Choice Replacement project over the initial term to December 2016 is £309.4m including contingency & inflation as per the Business Case. The Business Case costs include contingencies and Clinical Commissioning Groups costs. The whole life cost is set to reduce as a result of contingency not included in the forecast, finalisation of Contract negotiations and as a result of delays to the delivery of the new services.
Notes1:
Notes2:
Sourcefile: IPA_2016.csv

Home Selection Search All Reports All Projects (+dates) All Projects (+costs) All Organisations All Years All Categories


Acknowledgement: GMPP data has been re-used under the Open Government Licence.